Harmony Biosciences Holdings, Inc. (HRMY) Financials

HRMY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.4 billion 373.8 million
March 31, 2026 1.3 billion 361.5 million
Dec. 31, 2025 1.3 billion 401.4 million
Sept. 30, 2025 1.2 billion 373.1 million

HRMY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 92.4 million 9.3 million
March 31, 2026 27.8 million 10.6 million
Dec. 31, 2025 126.0 million 10.2 million
Sept. 30, 2025 108.7 million 10.8 million

HRMY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 75.4 million
March 31, 2026 32.5 million
Dec. 31, 2025 22.5 million
Sept. 30, 2025 50.9 million

HRMY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 667.8 million 134.0 million -
March 31, 2026 640.9 million 138.8 million 4.5 million
Dec. 31, 2025 775.3 million 148.2 million 4.5 million
Sept. 30, 2025 672.6 million 148.5 million 1.2 million

HRMY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 58.8 million
March 31, 2026 58.8 million
Dec. 31, 2025 58.7 million
Sept. 30, 2025 58.7 million

HRMY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 46.6 million 62.2 million 34.1 million
March 31, 2026 - 69.4 million 64.2 million 31.7 million
Dec. 31, 2025 107000 49.9 million 86.7 million 29.2 million
Sept. 30, 2025 71000 55.0 million 59.4 million 29.5 million

HRMY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 261.3 million 63.2 million
March 31, 2026 215.4 million 44.5 million
Dec. 31, 2025 243.8 million 68.5 million
Sept. 30, 2025 239.5 million 59.7 million

HRMY

Price: $38.12

52 week price:
25.52
40.87

Payout Ratio Range:
-21799.51%
207.69%

Earnings Per Share: 3.14 USD

P/E Ratio: 12.42

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 87588

Market Capitalization: 2.3 billion

Links: